Samsung Biologics Co Ltd
KRX:207940
Samsung Biologics Co Ltd
KRX:207940
Price:
999 999.9999
KRW
Market Closed
Market Cap:
₩82.3T
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Popular Picks
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
190.3
Current
200%
Cheaper
vs 3-y average of -190.4
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
P/FCFE
=
190.3
Market Cap
/
₩82.3T
Free Cash Flow to Equity
₩432.4B
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
P/FCFE
=
190.3
Market Cap
/
₩82.3T
Free Cash Flow to Equity
₩432.4B
P/FCFE Valuation Scenarios
Samsung Biologics Co Ltd is trading below its Industry Average
If P/FCFE returns to its Industry Average (310.5), the stock would be worth ₩1 631 435.24 (63% upside :side from current price).
Statistics
Positive Scenarios
1/2
Maximum Downside
-92%
Maximum Upside
+63%
Average Downside
14%
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 190.3 | ₩1 000 000 |
0%
|
| Industry Average | 310.5 | ₩1 631 435.24 |
+63%
|
| Country Average | 15.1 | ₩79 128.57 |
-92%
|
Forward P/FCFE
Today's price vs future Free Cash Flow to Equity
Not enough data available to calculate forward P/FCFE
